NO20055990L - Anvendelse av et polypeptid - Google Patents

Anvendelse av et polypeptid

Info

Publication number
NO20055990L
NO20055990L NO20055990A NO20055990A NO20055990L NO 20055990 L NO20055990 L NO 20055990L NO 20055990 A NO20055990 A NO 20055990A NO 20055990 A NO20055990 A NO 20055990A NO 20055990 L NO20055990 L NO 20055990L
Authority
NO
Norway
Prior art keywords
polypeptide
biotinylated
modulate
enzyme
derivative
Prior art date
Application number
NO20055990A
Other languages
English (en)
Norwegian (no)
Inventor
Norbert Tennagels
Aimo Kannt
Harald Thuering
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Publication of NO20055990L publication Critical patent/NO20055990L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • C12Q1/485Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving kinase
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value
    • G01N2500/04Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
NO20055990A 2003-05-22 2005-12-16 Anvendelse av et polypeptid NO20055990L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10323081A DE10323081A1 (de) 2003-05-22 2003-05-22 Verwendung eines Polypeptides
PCT/EP2004/004428 WO2004104220A2 (de) 2003-05-22 2004-04-27 Verwendung eines biotinylierten polypeptides zur bestimmung der aktivität von protein-phosphorylierenden enzymen

Publications (1)

Publication Number Publication Date
NO20055990L true NO20055990L (no) 2006-02-14

Family

ID=33441119

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20055990A NO20055990L (no) 2003-05-22 2005-12-16 Anvendelse av et polypeptid

Country Status (14)

Country Link
US (1) US7732151B2 (de)
EP (1) EP1627073A2 (de)
JP (1) JP4740858B2 (de)
KR (1) KR20060015290A (de)
CN (1) CN100560732C (de)
AU (1) AU2004241327B2 (de)
BR (1) BRPI0410783A (de)
CA (1) CA2526697A1 (de)
DE (1) DE10323081A1 (de)
IL (1) IL172008A (de)
MX (1) MXPA05012521A (de)
NO (1) NO20055990L (de)
RU (1) RU2395813C2 (de)
WO (1) WO2004104220A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2945263A1 (en) 2014-04-09 2015-10-15 Christopher Rudd Use of gsk-3 inhibitors or activators which modulate pd-1 or t-bet expression to modulate t cell immunity
CN113933463B (zh) * 2021-10-14 2024-04-02 丽江英煌集生物工程有限公司 一种玛咖多肽活性的快速分检装置及分检方法
CN115851602A (zh) * 2022-10-10 2023-03-28 安阳师范学院 一种kras点突变的肿瘤细胞及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0711341A4 (de) * 1993-07-29 2001-12-19 Cor Therapeutics Inc Rezeptorfunktionstests
US5763198A (en) * 1994-07-22 1998-06-09 Sugen, Inc. Screening assays for compounds
EP0873142A4 (de) * 1995-06-07 2001-08-08 Sugen Inc Überprüfungsteste für verbindungen
US5759787A (en) * 1996-08-26 1998-06-02 Tularik Inc. Kinase assay
ATE296446T1 (de) * 1997-01-15 2005-06-15 Telik Inc Modulatoren von insulinrezeptor-aktivität
DK1036192T3 (da) * 1997-12-05 2003-06-10 Upjohn Co Fluorescensbaserede screeningsanalyser med høj hastighedforproteinkinaser og phosphataser
DE60045586D1 (de) * 1999-06-09 2011-03-10 Molecular Devices Inc Testverfahren zur messung der phosphorylierung

Also Published As

Publication number Publication date
BRPI0410783A (pt) 2006-06-20
WO2004104220A2 (de) 2004-12-02
WO2004104220A3 (de) 2005-06-09
MXPA05012521A (es) 2006-05-25
IL172008A (en) 2011-12-29
US7732151B2 (en) 2010-06-08
HK1092840A1 (zh) 2007-02-16
RU2395813C2 (ru) 2010-07-27
CN100560732C (zh) 2009-11-18
JP2007512802A (ja) 2007-05-24
KR20060015290A (ko) 2006-02-16
JP4740858B2 (ja) 2011-08-03
DE10323081A1 (de) 2004-12-16
CA2526697A1 (en) 2004-12-02
US20080020399A1 (en) 2008-01-24
CN1795273A (zh) 2006-06-28
RU2005140091A (ru) 2006-05-10
AU2004241327B2 (en) 2010-03-25
AU2004241327A1 (en) 2004-12-02
EP1627073A2 (de) 2006-02-22

Similar Documents

Publication Publication Date Title
NO20052928L (no) Nye kjemiske forbindelser
NO20070950L (no) Preparater og fremgangsmater for anvendelse av angiopoietinlignende-4-protein.
NO20015096L (no) Måling og bruk av molekul¶re interaksjoner
DE602004006433D1 (de) Pyrrol-substituierte indole als inhibitoren von pai-1
SE0102620D0 (sv) Golvskivor med tätningsorgan
DE60039616D1 (de) INHIBITOREN DER c-JUN N-TERMINALEN KINASE (JNK) UND ANDERE PROTEIN-KINASEN
DE69731226D1 (de) Verwendung von substrat-subtraktionsbibliotheken zur unterscheidung von enzymspezifitäten
NO20045429L (no) Kombinasjon av organiske forbindelser
DE60136546D1 (de) Methode zum bekämpfen der allergien durch verwendung von substituierten pyrazolen
NO20040211L (no) Kombinasjon av en aldosteronreseptor for antagonist og en HMB COA-reduktaseinhibitor
PH12012502411A1 (en) Method of modulating stress-activated protein kinase system
NO20044051L (no) Analyse for ACTRIIB-kinase aktivitet
NO20056046L (no) Oralt dispergerbar flerlags tablett
SE0102426D0 (sv) Fuktsensor
DE602004017486D1 (de) Substituierte heteroarylbenzofuransäuren
ATE322361T1 (de) Isothiazolone/amine oxide holzschutzmittel
NO20053111L (no) Peptider som inhiberer angiogenese, cellemigrering, celleinvasjon og celleproliferering.
SG153662A1 (en) Bias sensing in dram sense amplifiers
ATE484749T1 (de) Von anti-trichinella-antikörpern erkannte polypeptide und ihre verwendung
NO20055990L (no) Anvendelse av et polypeptid
DE60329326D1 (de) Tace inhibitoren
DK2076532T3 (da) Cytokinderivater
DE502004009217D1 (de) Differenzialdiagnostik mit Hepcidin
DK1125903T3 (da) Træuldsbyggeelement og fremgangsmåde til fremstilling deraf
NO20031745L (no) Inhibisjon av vekstfaktoravhengigheten til tumorceller